The Novel Methylation Biomarker SCARA5 Sensitizes Cancer Cells to DNA Damage Chemotherapy Drugs in NSCLC

The Novel Methylation Biomarker SCARA5 Sensitizes Cancer Cells to DNA Damage Chemotherapy Drugs in NSCLC

BackgroundScavenger Receptor Class A Member 5 (SCARA5), also known as TESR, is expressed in various tissues and organs and participates in host defense. Recent studies have found SCARA5 to produce an anti-tumor effect for multiple tumors, although the mechanistic basis for the effect is unknown.Meth...

Full description

Bibliographic Details
Main Authors: Qi Peng, Yan Liu, Xuehua Kong, Jie Xian, Lin Ye, Li Yang, Shuliang Guo, Yan Zhang, Lan Zhou, Tingxiu Xiang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Oncology
Subjects:
tumor marker
SCARA5
CpG methylation
FOXM1
non-small cell lung cancer
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.666589/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.666589/full

Similar Items